Next-generation instruments improve rare-cell detection, sterility control, biosafety, and throughput for translational ...
IMU Biosciences, a biotechnology company decoding the immune system to pioneer a paradigm shift in how understand, diagnose, and treat disease, and Waters Corporation, a global leader in life sciences ...
Waters Corporation (NYSE: WAT) and IMU Biosciences have formed a strategic partnership to advance an AI-powered immune mapping platform targeting earlier disease diagnosis, ongoing monitoring, and ...
CytoFLEX nano Flow Cytometer provides high sensitivity and high resolution, enabling detection and characterization of nanoparticles at least as small as 40nm (based on polystyrene beads), accurately ...
IMU’s AI platform unlocks unprecedented immune insights for cancer and other diseases, measuring 100M+ data points from a single blood sample, analyzed in real time. Waters Biosciences’ technologies, ...
IMU Biosciences, a biotechnology company decoding the immune system to pioneer a paradigm shift in how we understand, diagnose, and treat disease, and Waters Corporation (NYSE: WAT) today announced a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results